Exhibit II
to
Schedule 13G
Joint Filing Agreement
The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 14, 2020 in connection with their beneficial ownership of Kiniksa Pharmaceuticals, Ltd. Each of, Columbia Wanger Asset Management, LLC and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
| Ameriprise Financial, Inc. | ||
| By: | /s/ Michael G. Clarke | |
| Name: | Michael G. Clarke | |
| Title: | Vice President,Co-Head of Global Operations | |
| Columbia Management Investment Advisers, LLC | ||
| By: | /s/ Michael G. Clarke | |
| Name: | Michael G. Clarke | |
| Title: | Vice President,Co-Head of Global Operations | |
| Columbia Wanger Asset Management, LLC | ||
| By: | /s/ Joseph C. LaPalm | |
| Name: | Joseph C. LaPalm | |
| Title: | Chief Compliance Officer | |
